C220H219F5N36O27 — CID 162234262
4-[(6-fluoro-3-pyridinyl)methyl]-N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyrazole-1-carboxamide;4-[(6-fluoro-2-pyridinyl)methyl]-N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-3-pyridinyl)methyl]pyrazole-1-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-2-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-(pyridin-3-ylmethyl)pyrazole-1-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[[6-(trifluoromethyl)-2-pyridinyl]methyl]pyrazole-1-carboxamide;N-[(3S)-8-[2-(3-hydroxyoxetan-3-yl)ethynyl]-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-2-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3S)-8-[2-(3-hydroxyoxetan-3-yl)ethynyl]-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-oxo-1H-pyridin-2-yl)methyl]pyridine-2-carboxamide (PubChem CID 162234262) has the molecular formula C220H219F5N36O27 and a molecular weight of 3894.39 g/mol. Its IUPAC name is 4-[(6-fluoro-3-pyridinyl)methyl]-N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyrazole-1-carboxamide;4-[(6-fluoro-2-pyridinyl)methyl]-N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-3-pyridinyl)methyl]pyrazole-1-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-2-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-(pyridin-3-ylmethyl)pyrazole-1-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[[6-(trifluoromethyl)-2-pyridinyl]methyl]pyrazole-1-carboxamide;N-[(3S)-8-[2-(3-hydroxyoxetan-3-yl)ethynyl]-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-2-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3S)-8-[2-(3-hydroxyoxetan-3-yl)ethynyl]-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-oxo-1H-pyridin-2-yl)methyl]pyridine-2-carboxamide.
| Compound Name | 4-[(6-fluoro-3-pyridinyl)methyl]-N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyrazole-1-carboxamide;4-[(6-fluoro-2-pyridinyl)methyl]-N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-3-pyridinyl)methyl]pyrazole-1-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-2-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-(pyridin-3-ylmethyl)pyrazole-1-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[[6-(trifluoromethyl)-2-pyridinyl]methyl]pyrazole-1-carboxamide;N-[(3S)-8-[2-(3-hydroxyoxetan-3-yl)ethynyl]-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-2-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3S)-8-[2-(3-hydroxyoxetan-3-yl)ethynyl]-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-oxo-1H-pyridin-2-yl)methyl]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 162234262 |
| Molecular Formula | C220H219F5N36O27 |
| Molecular Weight | 3894.39 g/mol |
| Exact Mass | 3891.68 |
| IUPAC Name | 4-[(6-fluoro-3-pyridinyl)methyl]-N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyrazole-1-carboxamide;4-[(6-fluoro-2-pyridinyl)methyl]-N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]pyridine-2-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-3-pyridinyl)methyl]pyrazole-1-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-2-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-(pyridin-3-ylmethyl)pyrazole-1-carboxamide;N-[(3S)-8-(3-hydroxy-3-methylbut-1-ynyl)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[[6-(trifluoromethyl)-2-pyridinyl]methyl]pyrazole-1-carboxamide;N-[(3S)-8-[2-(3-hydroxyoxetan-3-yl)ethynyl]-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-methyl-2-pyridinyl)methyl]pyridine-2-carboxamide;N-[(3S)-8-[2-(3-hydroxyoxetan-3-yl)ethynyl]-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-4-[(6-oxo-1H-pyridin-2-yl)methyl]pyridine-2-carboxamide |
| SMILES | CN1C(=O)[C@@H](NC(=O)c2cc(Cc3cccc(=O)[nH]3)ccn2)CCc2ccc(C#CC3(O)COC3)cc21.CN1C(=O)[C@@H](NC(=O)c2cc(Cc3cccc(F)n3)ccn2)CCc2ccc(C#CC(C)(C)O)cc21.CN1C(=O)[C@@H](NC(=O)n2cc(Cc3ccc(F)nc3)cn2)CCc2ccc(C#CC(C)(C)O)cc21.CN1C(=O)[C@@H](NC(=O)n2cc(Cc3cccc(C(F)(F)F)n3)cn2)CCc2ccc(C#CC(C)(C)O)cc21.CN1C(=O)[C@@H](NC(=O)n2cc(Cc3cccnc3)cn2)CCc2ccc(C#CC(C)(C)O)cc21.Cc1ccc(Cc2cnn(C(=O)N[C@H]3CCc4ccc(C#CC(C)(C)O)cc4N(C)C3=O)c2)cn1.Cc1cccc(Cc2ccnc(C(=O)N[C@H]3CCc4ccc(C#CC(C)(C)O)cc4N(C)C3=O)c2)n1.Cc1cccc(Cc2ccnc(C(=O)N[C@H]3CCc4ccc(C#CC5(O)COC5)cc4N(C)C3=O)c2)n1 |
| InChI | InChI=1S/C29H28N4O4.C29H30N4O3.C28H27FN4O3.C28H26N4O5.C27H26F3N5O3.C27H29N5O3.C26H26FN5O3.C26H27N5O3/c1-19-4-3-5-23(31-19)14-21-11-13-30-25(15-21)27(34)32-24-9-8-22-7-6-20(10-12-29(36)17-37-18-29)16-26(22)33(2)28(24)35;1-19-6-5-7-23(31-19)16-21-13-15-30-25(17-21)27(34)32-24-11-10-22-9-8-20(12-14-29(2,3)36)18-26(22)33(4)28(24)35;1-28(2,36)13-11-18-7-8-20-9-10-22(27(35)33(3)24(20)17-18)32-26(34)23-16-19(12-14-30-23)15-21-5-4-6-25(29)31-21;1-32-24-15-18(9-11-28(36)16-37-17-28)5-6-20(24)7-8-22(27(32)35)31-26(34)23-14-19(10-12-29-23)13-21-3-2-4-25(33)30-21;1-26(2,38)12-11-17-7-8-19-9-10-21(24(36)34(3)22(19)14-17)33-25(37)35-16-18(15-31-35)13-20-5-4-6-23(32-20)27(28,29)30;1-18-5-6-20(15-28-18)13-21-16-29-32(17-21)26(34)30-23-10-9-22-8-7-19(11-12-27(2,3)35)14-24(22)31(4)25(23)33;1-26(2,35)11-10-17-4-6-20-7-8-21(24(33)31(3)22(20)13-17)30-25(34)32-16-19(15-29-32)12-18-5-9-23(27)28-14-18;1-26(2,34)11-10-18-6-7-21-8-9-22(24(32)30(3)23(21)14-18)29-25(33)31-17-20(16-28-31)13-19-5-4-12-27-15-19/h3-7,11,13,15-16,24,36H,8-9,14,17-18H2,1-2H3,(H,32,34);5-9,13,15,17-18,24,36H,10-11,16H2,1-4H3,(H,32,34);4-8,12,14,16-17,22,36H,9-10,15H2,1-3H3,(H,32,34);2-6,10,12,14-15,22,36H,7-8,13,16-17H2,1H3,(H,30,33)(H,31,34);4-8,14-16,21,38H,9-10,13H2,1-3H3,(H,33,37);5-8,14-17,23,35H,9-10,13H2,1-4H3,(H,30,34);4-6,9,13-16,21,35H,7-8,12H2,1-3H3,(H,30,34);4-7,12,14-17,22,34H,8-9,13H2,1-3H3,(H,29,33)/t2*24-;2*22-;21-;23-;21-;22-/m00000000/s1 |
| InChIKey | ZVVUKMFULJFUDE-ZDMKEJIQSA-N |
| XLogP | 21.19 |
| TPSA | 821.51 Ų |
| H-Bond Donors | 17 |
| H-Bond Acceptors | 46 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 288 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3894.39 |
| LogP ≤ 5 | 21.19 |
| H-Bond Donors ≤ 5 | 17 |
| H-Bond Acceptors ≤ 10 | 46 |